HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Verrier, E. D. Articles by Morgan, E. N. Search for Related Content PubMed PubMed Citation Articles by Verrier, E. D. Articles by Morgan, E. N.

Ann Thorac Surg 1998;66:S17-S19
© 1998 The Society of Thoracic Surgeons

Endothelial response to cardiopulmonary bypass surgery

^a Division of Cardiothoracic Surgery, Department of Surgery, University of Washington, Seattle, Washington, USA

Address reprint requests to Dr Verrier, Cardiothoracic Surgery, University of Washington, 1959 NE Pacific St, Box 356310, Seattle, WA 98195

Presented at "Risk Management in CABG: Significant Surgical Considerations," New Orleans, LA, Jan 24, 1998.

Background. The vascular endothelium has been shown to actively participate in maintaining normal cardiovascular homeostasis by influencing the regulation of membrane permeability, lipid transport, vasomotor tone, coagulation, fibrinolysis, and inflammation. Endothelial cells are very responsive to a wide range of local and systemic stimuli that occur during cardiopulmonary bypass (CPB) operation. Major pathologic conditions result from impaired vascular function secondary to CPB, including vasospasm, coagulopathy, and widespread neutrophil adhesion secondary to a systemic inflammatory response. Additionally, more chronic responses to endothelial cell injury include the development of intimal hyperplasia and arteriosclerosis, both of which limit the long-term success of coronary artery bypass grafting.

Methods. Because of the increasingly recognized role of the endothelium in the maintenance of normal cardiovascular function, this article will review the normal structure and function of the endothelium, as well as the major pathologic conditions that result in response to CPB.

Results. Potential treatments to counteract endothelial cell dysfunction secondary to CPB are under active investigation. Strategies may be directed toward blocking single cytokines, integrins, or adhesion molecules involved in endothelial dysfunction or, alternatively, toward targeting a molecular event that governs the expression of these proinflammatory, procoagulant, and vasoactive genes. In our laboratory, we have used both strategies to study the pathologic response to CPB. We blocked neutrophil adhesion in subhuman primates with a monoclonal antibody. Alternatively, we targeted the transcriptional activation of multiple genes involved in the endothelial cell’s response to CPB.

Conclusions. Although both therapies help elucidate the multiple, redundant pathways involved in the pathologic response to CPB, it is through molecular biology that we are beginning to understand the mechanics of transcriptional control and translational expression that occurs in the endothelial cell in response to CPB. This knowledge will allow the development of therapies that inhibit not a single cytokine or adhesion molecule, but rather an array of substances that result in the endothelial cell’s pathologic response to CPB.

This article has been cited by other articles:

				Y F Cheung, X Ou, and S J Wong Central and peripheral arterial stiffness in patients after surgical repair of tetralogy of Fallot: implications for aortic root dilatation Heart, December 1, 2006; 92(12): 1827 - 1830. [Abstract] [Full Text] [PDF]

				M. Chello, C. Goffredo, G. Patti, D. Candura, R. Melfi, S. Mastrobuoni, G. Di Sciascio, and E. Covino Effects of atorvastatin on arterial endothelial function in coronary bypass surgery Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 805 - 810. [Abstract] [Full Text] [PDF]

				F. Onorati, L. Cristodoro, P. Mastroroberto, A. di Virgilio, A. Esposito, M. Bilotta, and A. Renzulli Should We Discontinue Intraaortic Balloon During Cardioplegic Arrest? Splanchnic Function Results of a Prospective Randomized Trial Ann. Thorac. Surg., December 1, 2005; 80(6): 2221 - 2228. [Abstract] [Full Text] [PDF]

				A. M. Morariu, Y. J. Gu, R. C.G. G. Huet, W. A. Siemons, G. Rakhorst, and W. v. Oeveren Red blood cell aggregation during cardiopulmonary bypass: a pathogenic cofactor in endothelial cell activation? Eur. J. Cardiothorac. Surg., November 1, 2004; 26(5): 939 - 946. [Abstract] [Full Text] [PDF]

				M. Yada, A. Shimamoto, C. R. Hampton, A. J. Chong, H. Takayama, C. L. Rothnie, D. J. Spring, H. Shimpo, I. Yada, T. H. Pohlman, et al. FR167653 diminishes infarct size in a murine model of myocardial ischemia-reperfusion injury J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 588 - 594. [Abstract] [Full Text] [PDF]

				F. Doguet, P.-Y. Litzler, F. Tamion, V. Richard, M.-F. Hellot, C. Thuillez, A. Tabley, F. Bouchart, and J. P. Bessou Changes in mesenteric vascular reactivity and inflammatory response after cardiopulmonary bypass in a rat model Ann. Thorac. Surg., June 1, 2004; 77(6): 2130 - 2137. [Abstract] [Full Text] [PDF]

				B. Wei, Y. Liu, Q. Wang, C. Yu, C. Long, Y. Chang, and Y. Ruan Lung perfusion with protective solution relieves lung injury in corrections of Tetralogy of Fallot Ann. Thorac. Surg., March 1, 2004; 77(3): 918 - 924. [Abstract] [Full Text] [PDF]

				A. J. Chong, T. H. Pohlman, C. R. Hampton, A. Shimamoto, N. Mackman, and E. D. Verrier Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury Ann. Thorac. Surg., February 1, 2003; 75(2): S649 - 655. [Abstract] [Full Text] [PDF]

				C. Bianchi, E. G. Araujo, K. Sato, and F. W. Sellke Biochemical and Structural Evidence for Pig Myocardium Adherens Junction Disruption by Cardiopulmonary Bypass Circulation, September 18, 2001; 104(90001): I-319 - 324. [Abstract] [Full Text] [PDF]

				K. Kottke-Marchant and S. Sapatnekar Hemostatic Abnormalities in Cardiopulmonary Bypass: Pathophysiologic and Transfusion Considerations Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 187 - 206. [Abstract] [PDF]

				E. G. Araujo, C. Bianchi, K. Sato, R. Faro, X. A. Li, and F. W. Sellke Inactivation of the MEK/ERK pathway in the myocardium during cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 773 - 781. [Abstract] [Full Text] [PDF]

				C Jaggy, M Lachat, B Leskosek, G Zund, and M Turina Affinity pump system: a new peristaltic blood pump for cardiopulmonary bypass Perfusion, January 1, 2000; 15(1): 77 - 83. [Abstract] [PDF]